FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2023/11/060376 [Registered on: 30/11/2023] Trial Registered Prospectively
Last Modified On: 29/11/2023
Post Graduate Thesis  Yes 
Type of Trial  Interventional 
Type of Study   Surgical/Anesthesia 
Study Design  Randomized, Parallel Group Trial 
Public Title of Study   Comparison of Two Designs of Nasolabial Flaps in Patients Undergoing Surgical Intervention for Oral Submucous Fibrosis 
Scientific Title of Study   Comparative Evaluation of Conventional Nasolabial flap and Nasolabial flap with Fishtail Modification in patients undergoing surgical release of fibrous bands in Oral Submucous Fibrosis  
Trial Acronym   
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Nikhar Wadhwani 
Designation  PG Student 
Affiliation  Datta Meghe Institute of Higher Education 
Address  Datta Meghe Institute of Higher Education, Sawangi, Wardha, Maharashtra
Datta Meghe Institute of Medical Sciences, Sawangi, Wardha, Maharashtra
Wardha
MAHARASHTRA
442004
India 
Phone  8007808088  
Fax    
Email  nikhar.wadhwani@gmail.com  
 
Details of Contact Person
Scientific Query
 
Name  Nitin Bhola 
Designation  Professor and Head, Department of Oral and Maxillofacial Surgery 
Affiliation  Datta Meghe Institute of Higher Education 
Address  Datta Meghe Institute of Higher Education, Sawangi, Wardha, Maharashtra
Datta Meghe Institute of Higher Education, Sawangi, Wardha, Maharashtra
Wardha
MAHARASHTRA
442004
India 
Phone  8007808088  
Fax    
Email  drnitinbhola@gmail.com  
 
Details of Contact Person
Public Query
 
Name  Nikhar Wadhwani 
Designation  PG Student 
Affiliation  Datta Meghe Institute of Higher Education 
Address  Datta Meghe Institute of Higher Education, Sawangi, Wardha, Maharashtra
Datta Meghe Institute of Higher Education, Sawangi, Wardha, Maharashtra
Wardha
MAHARASHTRA
442004
India 
Phone  8007808088  
Fax    
Email  nikhar.wadhwani@gmail.com  
 
Source of Monetary or Material Support  
Datta Meghe Institute of Higher Education, Sawangi, Wardha, Maharashtra, India - 442004 
 
Primary Sponsor  
Name  Datta Meghe Institute of Medical Sciences 
Address  Sawangi, Meghe 
Type of Sponsor  Research institution and hospital 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Dr Nikhar  Acharya Vinobha Bhave Rural Hospital, Sawangi, Wardha, Maharashtra 442001  Department of Oral and Maxillofacial Surgery
Wardha
MAHARASHTRA 
8007808088

nikhar.wadhwani@gmail.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
INSTITUTIONAL ETHICS COMMITTEE, DATTA MEGHE INSTITUTE OF MEDICAL SCIENCES  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition: K135||Oral submucous fibrosis, (2) ICD-10 Condition: K135||Oral submucous fibrosis,  
 
Intervention / Comparator Agent  
Type  Name  Details 
Comparator Agent  Conventional Nasolabial Flap  This is the flap commonly used, which often causes widening of oral commissure. This will be evaluated over a period of 6 months post-operatively. 
Intervention  Fishtail modification of Nasolabial flap  This is a modification of the conventional flap which we hypothesize will have lower commissure widening and better overall esthetics. This will be evaluated over a period of 6 months post-operatively. 
 
Inclusion Criteria  
Age From  18.00 Year(s)
Age To  60.00 Year(s)
Gender  Both 
Details  Patients with Grade IV OSMF 
 
ExclusionCriteria 
Details   
 
Method of Generating Random Sequence    
Method of Concealment    
Blinding/Masking    
Primary Outcome  
Outcome  TimePoints 
Functional outcomes: Rate of flap failure  Follow up at 2 weeks and 4 weeks 
 
Secondary Outcome  
Outcome  TimePoints 
Aesthetic outcomes: Widening of oral commissure, tearing at corner of mouth  Follow up at 2 weeks & 4 weeks 
 
Target Sample Size   Total Sample Size="20"
Sample Size from India="20" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   N/A 
Date of First Enrollment (India)   07/12/2023 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  07/12/2023 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="1"
Months="6"
Days="0" 
Recruitment Status of Trial (Global)   Open to Recruitment 
Recruitment Status of Trial (India)  Not Yet Recruiting 
Publication Details   N/A 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - YES
  1. What data in particular will be shared?
    Response - Individual participant data that underlie the results reported in this article, after de-identification (text, tables, figures, and appendices).

  2. What additional supporting information will be shared?
    Response -  Study Protocol
    Response -  Statistical Analysis Plan
    Response - Informed Consent Form
    Response - Clinical Study Report
    Response -  Analytic Code

  3. Who will be able to view these files?
    Response - Researchers who provide a methodologically sound proposal.

  4. For what types of analyses will this data be available?
    Response - Any purpose.

  5. By what mechanism will data be made available?
    Response - Proposals should be directed to [nikhar.wadhwani@gmail.com].

  6. For how long will this data be available start date provided 01-03-2024 and end date provided 01-03-2027?
    Response - Beginning 3 months and ending 5 years following article publication.

  7. Any URL or additional information regarding plan/policy for sharing IPD? 
    Additional Information - NIL
Brief Summary   Oral submucous fibrosis is a widespread condition affecting millions in the South Asian subcontinent. It is mainly prevalent due to the habitual consumption of Betel Nut, a variety of smokeless tobacco, which causes severe fibrosis of the oral mucosa, eventually leading to depleted quality of life due to reduction in mouth opening. 
There are various treatment modalities available, but surgery remains the one with best outcomes. Different flaps have been used to reconstruct the fibrotomy defect, the nasolabial flap is mostly preferred due to its versatility. We have brought forth a modification of this flap which will hypothetically reduce certain post operative complications such as tearing of the oral commissure, angular cheilitis, and widening of the corner of mouth.
 
Close